![Sunil Karnawat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sunil Karnawat
Corporate Officer/Principal bei
REZOLUTE, INC.
Vermögen: 117 671 $ am 30.09.2026
Profil
Sunil Karnawat currently works at Rezolute, Inc., as Chief Commercial Officer from 2025.
Dr. Karnawat also formerly worked at Cytokinetics, Inc., as Vice President and Ultragenyx Pharmaceutical, Inc., as Vice President.
Dr. Karnawat received his graduate degree and doctorate degree from North Dakota State University, undergraduate degree from College of Engineering, Pune, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REZOLUTE, INC. 0,03 % | 21.09.2026 | 28.423 ( 0,03 % ) | 117 671 $ | 30.09.2026 |
Aktive Positionen von Sunil Karnawat
| Unternehmen | Position | Beginn |
|---|---|---|
| REZOLUTE, INC. | Corporate Officer/Principal | 18.08.2025 |
Ehemalige bekannte Positionen von Sunil Karnawat
| Unternehmen | Position | Ende |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Ausbildung von Sunil Karnawat
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
North Dakota State University
 North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Engineering, Pune
 College of Engineering, Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
